Difference between revisions of "Example orders for Carboplatin (Paraplatin) and Pemetrexed (Alimta) in non-small cell lung cancer"
Jump to navigation
Jump to search
Warner-admin (talk | contribs) m (Text replacement - "Just 10 days left" to "Just 9 days left") |
Warner-admin (talk | contribs) m (Text replacement - " " to " ") |
||
| (8 intermediate revisions by 2 users not shown) | |||
| Line 1: | Line 1: | ||
| − | + | <!--'''Use of this site is subject to you reading and agreeing with the terms set forth in the [[HemOnc.org_-_A_Hematology_Oncology_Wiki:General_disclaimer|disclaimer]]. If this is your first time visiting, we suggest you read the [[tutorial]].'''--> | |
| − | |||
| − | < | ||
| − | |||
| − | |||
| − | |||
Remember that example order sets that may contain additional information about supportive medications, suggestions for monitoring, hydration, and pre-treatment screening information for chemotherapy regimens are purely anecdotal, provided only as examples of what some other providers may be using, and are typically not based on references in the primary literature. | Remember that example order sets that may contain additional information about supportive medications, suggestions for monitoring, hydration, and pre-treatment screening information for chemotherapy regimens are purely anecdotal, provided only as examples of what some other providers may be using, and are typically not based on references in the primary literature. | ||
| Line 20: | Line 15: | ||
'''21-day cycles x 6 cycles''' | '''21-day cycles x 6 cycles''' | ||
| − | ====Supportive | + | ====Supportive therapy==== |
| − | *Ondansetron (Zofran) 8 mg IV 30 minutes prior to chemotherapy | + | *Ondansetron (Zofran) 8 mg IV 30 minutes prior to chemotherapy |
| − | *Lorazepam (Ativan) 0.5-1 mg PO | + | *Lorazepam (Ativan) 0.5-1 mg IV or PO x 1 prn nausea/anxiety |
| − | *Prochlorperazine (Compazine) 10 mg PO x 1 prn nausea | + | *Prochlorperazine (Compazine) 10 mg PO x 1 prn nausea |
| − | *[[Dexamethasone (Decadron)]] 4 mg PO | + | *[[Dexamethasone (Decadron)]] 4 mg PO twice per day the day before, day of, and day after chemotherapy |
*[[Cyanocobalamin (Vitamin B12)]] 1000 mcg IM every 9 weeks, the first dose given at least 1 week prior to start of pemetrexed therapy | *[[Cyanocobalamin (Vitamin B12)]] 1000 mcg IM every 9 weeks, the first dose given at least 1 week prior to start of pemetrexed therapy | ||
*Folic acid 1000 mcg PO daily, to start at least 1 week prior to start of pemetrexed therapy, to continue throughout therapy with pemetrexed | *Folic acid 1000 mcg PO daily, to start at least 1 week prior to start of pemetrexed therapy, to continue throughout therapy with pemetrexed | ||
| Line 34: | Line 29: | ||
*On day 1 of each cycle: CBC with differential, absolute neutrophil count (ANC), BUN/Cr as part of a basic metabolic panel, alk phos, AST, ALT, total bilirubin, albumin, carcinoembryonic antigen | *On day 1 of each cycle: CBC with differential, absolute neutrophil count (ANC), BUN/Cr as part of a basic metabolic panel, alk phos, AST, ALT, total bilirubin, albumin, carcinoembryonic antigen | ||
**Depending on provider preference and patient's tolerance, may simplify to CBC with differential, absolute neutrophil count (ANC), BUN/Cr | **Depending on provider preference and patient's tolerance, may simplify to CBC with differential, absolute neutrophil count (ANC), BUN/Cr | ||
| − | *On cycle 1 day 10, check nadir CBC with differential, absolute neutrophil count (ANC). | + | *On cycle 1 day 10, check nadir CBC with differential, absolute neutrophil count (ANC). Need for further nadir count checks to be determined by degree of cytopenias. |
*Assess for response with CT scan after cycle 3 | *Assess for response with CT scan after cycle 3 | ||
Outpatient medications: | Outpatient medications: | ||
*[[Dexamethasone (Decadron)]] as described above | *[[Dexamethasone (Decadron)]] as described above | ||
| − | *Lorazepam (Ativan) 0.5 mg PO | + | *Lorazepam (Ativan) 0.5 mg PO every 6 hours prn anxiety, insomnia, nausea |
| − | *Ondansetron (Zofran) 4 mg PO | + | *Ondansetron (Zofran) 4 mg PO every 6 hours prn nausea |
| − | *Prochlorperazine (Compazine) 10 mg PO | + | *Prochlorperazine (Compazine) 10 mg PO every 6 hours prn nausea |
*Folic acid 1000 mcg PO daily as described above | *Folic acid 1000 mcg PO daily as described above | ||
*Due to refractory nausea, in later cycles, we eventually added Aprepitant (Emend) 125 mg PO on day 1, 80 mg PO on days 2 to 3, and [[Dexamethasone (Decadron)]] use was extended to include day -1 through day 4 | *Due to refractory nausea, in later cycles, we eventually added Aprepitant (Emend) 125 mg PO on day 1, 80 mg PO on days 2 to 3, and [[Dexamethasone (Decadron)]] use was extended to include day -1 through day 4 | ||
'''Clinical scenario & comments:''' | '''Clinical scenario & comments:''' | ||
| − | *60 year-old lady with stage IV adenocarcinoma of the lung, treated with first-line therapy for metastatic disease. | + | *60 year-old lady with stage IV adenocarcinoma of the lung, treated with first-line therapy for metastatic disease. Our institution's standard order set uses Carboplatin (Paraplatin) at AUC 5. This is reasonable in my view; the patient also had a history of pelvic radiation and chemotherapy for an unrelated malignancy many years ago. This was subsequently followed by [[Non-small cell lung cancer#Pemetrexed_monotherapy|Pemetrexed (Alimta) maintenance therapy]]. |
[[Category:Example chemotherapy order sets]] | [[Category:Example chemotherapy order sets]] | ||
Latest revision as of 01:58, 1 June 2023
Remember that example order sets that may contain additional information about supportive medications, suggestions for monitoring, hydration, and pre-treatment screening information for chemotherapy regimens are purely anecdotal, provided only as examples of what some other providers may be using, and are typically not based on references in the primary literature.
Carboplatin (Paraplatin) & Pemetrexed (Alimta)
Original references may be found at Carboplatin (Paraplatin) & Pemetrexed (Alimta)
Example regimen #1
- Carboplatin (Paraplatin) AUC 5 IV on day 1
- Infuse over 30-60 minutes.
- Pemetrexed (Alimta) 500 mg/m2 IV on day 1
- Administer over 10 minutes. Administer after carboplatin.
21-day cycles x 6 cycles
Supportive therapy
- Ondansetron (Zofran) 8 mg IV 30 minutes prior to chemotherapy
- Lorazepam (Ativan) 0.5-1 mg IV or PO x 1 prn nausea/anxiety
- Prochlorperazine (Compazine) 10 mg PO x 1 prn nausea
- Dexamethasone (Decadron) 4 mg PO twice per day the day before, day of, and day after chemotherapy
- Cyanocobalamin (Vitamin B12) 1000 mcg IM every 9 weeks, the first dose given at least 1 week prior to start of pemetrexed therapy
- Folic acid 1000 mcg PO daily, to start at least 1 week prior to start of pemetrexed therapy, to continue throughout therapy with pemetrexed
Hydration:
- 500 ml NS and/or D5W at KVO rate as running IV for chemotherapy infusion. Give up to 500 ml NS and/or D5W as needed for IV compatibility.
Monitoring:
- On day 1 of each cycle: CBC with differential, absolute neutrophil count (ANC), BUN/Cr as part of a basic metabolic panel, alk phos, AST, ALT, total bilirubin, albumin, carcinoembryonic antigen
- Depending on provider preference and patient's tolerance, may simplify to CBC with differential, absolute neutrophil count (ANC), BUN/Cr
- On cycle 1 day 10, check nadir CBC with differential, absolute neutrophil count (ANC). Need for further nadir count checks to be determined by degree of cytopenias.
- Assess for response with CT scan after cycle 3
Outpatient medications:
- Dexamethasone (Decadron) as described above
- Lorazepam (Ativan) 0.5 mg PO every 6 hours prn anxiety, insomnia, nausea
- Ondansetron (Zofran) 4 mg PO every 6 hours prn nausea
- Prochlorperazine (Compazine) 10 mg PO every 6 hours prn nausea
- Folic acid 1000 mcg PO daily as described above
- Due to refractory nausea, in later cycles, we eventually added Aprepitant (Emend) 125 mg PO on day 1, 80 mg PO on days 2 to 3, and Dexamethasone (Decadron) use was extended to include day -1 through day 4
Clinical scenario & comments:
- 60 year-old lady with stage IV adenocarcinoma of the lung, treated with first-line therapy for metastatic disease. Our institution's standard order set uses Carboplatin (Paraplatin) at AUC 5. This is reasonable in my view; the patient also had a history of pelvic radiation and chemotherapy for an unrelated malignancy many years ago. This was subsequently followed by Pemetrexed (Alimta) maintenance therapy.